PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FAD2F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $15,684
Award facts
- Contract value 100% obligated
- $15,683.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,683.84 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive portfolio of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs globally, including critical commodities such as specialty medications, vaccines, syringes, vials, and test kits. The Defense Logistics Agency is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, positioning AmerisourceBergen Drug Corp alongside other strategic contractors to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2D826FAD2F?
SPE2D826FAD2F was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 1, 2025.
How much is contract SPE2D826FAD2F worth?
The government has obligated $15,684 on SPE2D826FAD2F.
Is contract SPE2D826FAD2F an order under another contract?
Yes. SPE2D826FAD2F is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAD2F competed?
The extent of competition for SPE2D826FAD2F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award